Pharmacokinetics, Safety and Tolerability Study of AVT04 to EU Approved and US Licensed Stelara (Ustekinumab)
Clinical trial NCT04744363 · COMPLETED
Trial details
- NCT number
- NCT04744363
- Sponsor
- Alvotech Swiss AG
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-25
- Primary completion
- 2022-03-19
- Enrollment
- 294
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.